Skip to main content
Top
Published in: BMC Cancer 1/2011

Open Access 01-12-2011 | Research article

A functional and transcriptomic analysis of NET1 bioactivity in gastric cancer

Authors: Gayle Bennett, Denise Sadlier, Peter P Doran, Padraic MacMathuna, David W Murray

Published in: BMC Cancer | Issue 1/2011

Login to get access

Abstract

Background

NET1, a RhoA guanine exchange factor, is up-regulated in gastric cancer (GC) tissue and drives the invasive phenotype of this disease. In this study, we aimed to determine the role of NET1 in GC by monitoring the proliferation, motility and invasion of GC cells in which NET1 has been stably knocked down. Additionally, we aimed to determine NET1-dependent transcriptomic events that occur in GC.

Methods

An in vitro model of stable knockdown of NET1 was achieved in AGS human gastric adenocarcinoma cells via lentiviral mediated transduction of short-hairpin (sh) RNA targeting NET1. Knockdown was assessed using quantitative PCR. Cell proliferation was assessed using an MTS assay and cell migration was assessed using a wound healing scratch assay. Cell invasion was assessed using a transwell matrigel invasion assay. Gene expression profiles were examined using affymetrix oligonucleotide U133A expression arrays. A student's t test was used to determine changes of statistical significance.

Results

GC cells were transduced with NET1 shRNA resulting in a 97% reduction in NET1 mRNA (p < 0.0001). NET1 knockdown significantly reduced the invasion and migration of GC cells by 94% (p < 0.05) and 24% (p < 0.001) respectively, while cell proliferation was not significantly altered following NET1 knockdown. Microarray analysis was performed on non-target and knockdown cell lines, treated with and without 10 μM lysophosphatidic acid (LPA) allowing us to identify NET1-dependent, LPA-dependent and NET1-mediated LPA-induced gene transcription. Differential gene expression was confirmed by quantitative PCR. Shortlisted NET1-dependent genes included STAT1, TSPAN1, TGFBi and CCL5 all of which were downregulatd upon NET1 downregulation. Shortlisted LPA-dependent genes included EGFR and PPARD where EGFR was upregulated and PPARD was downregulated upon LPA stimulation. Shortlisted NET1 and LPA dependent genes included IGFR1 and PIP5K3. These LPA induced genes were downregulated in NET1 knockdown cells.

Conclusions

NET1 plays an important role in GC cell migration and invasion, key aspects of GC progression. Furthermore, the gene expression profile further elucidates the molecular mechanisms underpinning NET1-mediated aggressive GC cell behaviour.
Appendix
Available only for authorised users
Literature
1.
go back to reference Aurello P, D'Angelo F, Rossi S, et al: Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature. Am Surg. 2007, 73: 359-66.PubMed Aurello P, D'Angelo F, Rossi S, et al: Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature. Am Surg. 2007, 73: 359-66.PubMed
2.
go back to reference Saito H, Fukumoto Y, Osaki T, et al: Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer. J Surg Oncol. 2008, 97: 132-5. 10.1002/jso.20929.CrossRefPubMed Saito H, Fukumoto Y, Osaki T, et al: Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer. J Surg Oncol. 2008, 97: 132-5. 10.1002/jso.20929.CrossRefPubMed
3.
go back to reference Kim YJ, Kim MA, Im SA, et al: Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer. Cancer Invest. 2008, 26: 152-8. 10.1080/07357900701518909.CrossRefPubMed Kim YJ, Kim MA, Im SA, et al: Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer. Cancer Invest. 2008, 26: 152-8. 10.1080/07357900701518909.CrossRefPubMed
4.
go back to reference Kouraklis G, Katsoulis IE, Theocharis S, et al: Does the expression of cyclin E, pRb, and p21 correlate with prognosis in gastric adenocarcinoma?. Dig Dis Sci. 2009, 54: 1015-20. 10.1007/s10620-008-0464-y.CrossRefPubMed Kouraklis G, Katsoulis IE, Theocharis S, et al: Does the expression of cyclin E, pRb, and p21 correlate with prognosis in gastric adenocarcinoma?. Dig Dis Sci. 2009, 54: 1015-20. 10.1007/s10620-008-0464-y.CrossRefPubMed
5.
go back to reference Kim JS, Kim MA, Kim TM, et al: Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival. Br J Cancer. 2009, 100: 732-8. 10.1038/sj.bjc.6604936.CrossRefPubMedPubMedCentral Kim JS, Kim MA, Kim TM, et al: Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival. Br J Cancer. 2009, 100: 732-8. 10.1038/sj.bjc.6604936.CrossRefPubMedPubMedCentral
6.
go back to reference Leyden J, Murray D, Moss A, et al: NET1 and Myeov: computationally identified mediators of gastric cancer. Br J Cancer. 2006, 94: 1204-12. 10.1038/sj.bjc.6603054.CrossRefPubMedPubMedCentral Leyden J, Murray D, Moss A, et al: NET1 and Myeov: computationally identified mediators of gastric cancer. Br J Cancer. 2006, 94: 1204-12. 10.1038/sj.bjc.6603054.CrossRefPubMedPubMedCentral
7.
go back to reference Murray D, Horgan G, Macmathuna P, et al: NET1-mediated RhoA activation facilitates LPA-induced cell migration and invasion in gastric cancer. Br J Cancer. 2008, 99: 1322-9. 10.1038/sj.bjc.6604688.CrossRefPubMedPubMedCentral Murray D, Horgan G, Macmathuna P, et al: NET1-mediated RhoA activation facilitates LPA-induced cell migration and invasion in gastric cancer. Br J Cancer. 2008, 99: 1322-9. 10.1038/sj.bjc.6604688.CrossRefPubMedPubMedCentral
8.
go back to reference Hasegawa S, Furukawa Y, Li M, et al: Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res. 2002, 62: 7012-7.PubMed Hasegawa S, Furukawa Y, Li M, et al: Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res. 2002, 62: 7012-7.PubMed
9.
go back to reference Ji J, Chen X, Leung SY, et al: Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines. Oncogene. 2002, 21: 6549-56. 10.1038/sj.onc.1205829.CrossRefPubMed Ji J, Chen X, Leung SY, et al: Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines. Oncogene. 2002, 21: 6549-56. 10.1038/sj.onc.1205829.CrossRefPubMed
10.
go back to reference Hippo Y, Taniguchi H, Tsutsumi S, et al: Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res. 2002, 62: 233-40.PubMed Hippo Y, Taniguchi H, Tsutsumi S, et al: Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res. 2002, 62: 233-40.PubMed
11.
go back to reference Meireles SI, Carvalho AF, Hirata R, et al: Differentially expressed genes in gastric tumors identified by cDNA array. Cancer Lett. 2003, 190: 199-211. 10.1016/S0304-3835(02)00587-6.CrossRefPubMed Meireles SI, Carvalho AF, Hirata R, et al: Differentially expressed genes in gastric tumors identified by cDNA array. Cancer Lett. 2003, 190: 199-211. 10.1016/S0304-3835(02)00587-6.CrossRefPubMed
12.
go back to reference Yu CD, Xu SH, Mou HZ, et al: Gene expression profile differences in gastric cancer, pericancerous epithelium and normal gastric mucosa by gene chip. World J Gastroenterol. 2005, 11: 2390-7.CrossRefPubMedPubMedCentral Yu CD, Xu SH, Mou HZ, et al: Gene expression profile differences in gastric cancer, pericancerous epithelium and normal gastric mucosa by gene chip. World J Gastroenterol. 2005, 11: 2390-7.CrossRefPubMedPubMedCentral
13.
go back to reference Inoue H, Matsuyama A, Mimori K, et al: Prognostic score of gastric cancer determined by cDNA microarray. Clin Cancer Res. 2002, 8: 3475-9.PubMed Inoue H, Matsuyama A, Mimori K, et al: Prognostic score of gastric cancer determined by cDNA microarray. Clin Cancer Res. 2002, 8: 3475-9.PubMed
14.
go back to reference Chen CN, Lin JJ, Chen JJ, et al: Gene expression profile predicts patient survival of gastric cancer after surgical resection. J Clin Oncol. 2005, 23: 7286-95. 10.1200/JCO.2004.00.2253.CrossRefPubMed Chen CN, Lin JJ, Chen JJ, et al: Gene expression profile predicts patient survival of gastric cancer after surgical resection. J Clin Oncol. 2005, 23: 7286-95. 10.1200/JCO.2004.00.2253.CrossRefPubMed
15.
go back to reference Kang HC, Kim IJ, Park JH, et al: Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays. Clin Cancer Res. 2004, 10: 272-84. 10.1158/1078-0432.CCR-1025-3.CrossRefPubMed Kang HC, Kim IJ, Park JH, et al: Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays. Clin Cancer Res. 2004, 10: 272-84. 10.1158/1078-0432.CCR-1025-3.CrossRefPubMed
16.
go back to reference Kim HK, Choi IJ, Kim HS, et al: DNA microarray analysis of the correlation between gene expression patterns and acquired resistance to 5-FU/cisplatin in gastric cancer. Biochem Biophys Res Commun. 2004, 316: 781-9. 10.1016/j.bbrc.2004.02.109.CrossRefPubMed Kim HK, Choi IJ, Kim HS, et al: DNA microarray analysis of the correlation between gene expression patterns and acquired resistance to 5-FU/cisplatin in gastric cancer. Biochem Biophys Res Commun. 2004, 316: 781-9. 10.1016/j.bbrc.2004.02.109.CrossRefPubMed
17.
go back to reference Hofman VJ, Moreilhon C, Brest PD, et al: Gene expression profiling in human gastric mucosa infected with Helicobacter pylori. Mod Pathol. 2007, 20: 974-89. 10.1038/modpathol.3800930.CrossRefPubMed Hofman VJ, Moreilhon C, Brest PD, et al: Gene expression profiling in human gastric mucosa infected with Helicobacter pylori. Mod Pathol. 2007, 20: 974-89. 10.1038/modpathol.3800930.CrossRefPubMed
18.
go back to reference Backert S, Gressmann H, Kwok T, et al: Gene expression and protein profiling of AGS gastric epithelial cells upon infection with Helicobacter pylori. Proteomics. 2005, 5: 3902-18. 10.1002/pmic.200401240.CrossRefPubMed Backert S, Gressmann H, Kwok T, et al: Gene expression and protein profiling of AGS gastric epithelial cells upon infection with Helicobacter pylori. Proteomics. 2005, 5: 3902-18. 10.1002/pmic.200401240.CrossRefPubMed
19.
go back to reference Chiou CC, Chan CC, Sheu DL, et al: Helicobacter pylori infection induced alteration of gene expression in human gastric cells. Gut. 2001, 48: 598-604. 10.1136/gut.48.5.598.CrossRefPubMedPubMedCentral Chiou CC, Chan CC, Sheu DL, et al: Helicobacter pylori infection induced alteration of gene expression in human gastric cells. Gut. 2001, 48: 598-604. 10.1136/gut.48.5.598.CrossRefPubMedPubMedCentral
20.
go back to reference Schroeder A, Mueller O, Stocker S, et al: The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol. 2006, 7: 3-10.1186/1471-2199-7-3.CrossRefPubMedPubMedCentral Schroeder A, Mueller O, Stocker S, et al: The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol. 2006, 7: 3-10.1186/1471-2199-7-3.CrossRefPubMedPubMedCentral
21.
go back to reference Irizarry RA, Hobbs B, Collin F, et al: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003, 4: 249-64. 10.1093/biostatistics/4.2.249.CrossRefPubMed Irizarry RA, Hobbs B, Collin F, et al: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003, 4: 249-64. 10.1093/biostatistics/4.2.249.CrossRefPubMed
22.
go back to reference Newton MA, Kendziorski CM, Richmond CS, et al: On differential variability of expression ratios: improving statistical inference about gene expression changes from microarray data. J Comput Biol. 2001, 8: 37-52. 10.1089/106652701300099074.CrossRefPubMed Newton MA, Kendziorski CM, Richmond CS, et al: On differential variability of expression ratios: improving statistical inference about gene expression changes from microarray data. J Comput Biol. 2001, 8: 37-52. 10.1089/106652701300099074.CrossRefPubMed
23.
go back to reference Eisen MB, Spellman PT, Brown PO, et al: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998, 95: 14863-8. 10.1073/pnas.95.25.14863.CrossRefPubMedPubMedCentral Eisen MB, Spellman PT, Brown PO, et al: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998, 95: 14863-8. 10.1073/pnas.95.25.14863.CrossRefPubMedPubMedCentral
24.
go back to reference Kishino H, Waddell PJ: Correspondence analysis of genes and tissue types and finding genetic links from microarray data. Genome Inform Ser Workshop Genome Inform. 2000, 11: 83-95.PubMed Kishino H, Waddell PJ: Correspondence analysis of genes and tissue types and finding genetic links from microarray data. Genome Inform Ser Workshop Genome Inform. 2000, 11: 83-95.PubMed
25.
go back to reference Fellenberg K, Hauser NC, Brors B, et al: Correspondence analysis applied to microarray data. Proc Natl Acad Sci USA. 2001, 98: 10781-6. 10.1073/pnas.181597298.CrossRefPubMedPubMedCentral Fellenberg K, Hauser NC, Brors B, et al: Correspondence analysis applied to microarray data. Proc Natl Acad Sci USA. 2001, 98: 10781-6. 10.1073/pnas.181597298.CrossRefPubMedPubMedCentral
26.
go back to reference Gutkind JS, Crespo P, Xu N, et al: The pathway connecting m2 receptors to the nucleus involves small GTP-binding proteins acting on divergent MAP kinase cascades. Life Sci. 1997, 60: 999-1006. 10.1016/S0024-3205(97)00040-4.CrossRefPubMed Gutkind JS, Crespo P, Xu N, et al: The pathway connecting m2 receptors to the nucleus involves small GTP-binding proteins acting on divergent MAP kinase cascades. Life Sci. 1997, 60: 999-1006. 10.1016/S0024-3205(97)00040-4.CrossRefPubMed
27.
go back to reference Guo X, Stafford LJ, Bryan B, et al: A Rac/Cdc42-specific exchange factor, GEFT, induces cell proliferation, transformation, and migration. J Biol Chem. 2003, 278: 13207-15. 10.1074/jbc.M208896200.CrossRefPubMed Guo X, Stafford LJ, Bryan B, et al: A Rac/Cdc42-specific exchange factor, GEFT, induces cell proliferation, transformation, and migration. J Biol Chem. 2003, 278: 13207-15. 10.1074/jbc.M208896200.CrossRefPubMed
28.
go back to reference Minard ME, Kim LS, Price JE, et al: The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression. Breast Cancer Res Treat. 2004, 84: 21-32. 10.1023/B:BREA.0000018421.31632.e6.CrossRefPubMed Minard ME, Kim LS, Price JE, et al: The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression. Breast Cancer Res Treat. 2004, 84: 21-32. 10.1023/B:BREA.0000018421.31632.e6.CrossRefPubMed
29.
go back to reference Minard ME, Ellis LM, Gallick GE: Tiam1 regulates cell adhesion, migration and apoptosis in colon tumor cells. Clin Exp Metastasis. 2006, 23: 301-13. 10.1007/s10585-006-9040-z.CrossRefPubMed Minard ME, Ellis LM, Gallick GE: Tiam1 regulates cell adhesion, migration and apoptosis in colon tumor cells. Clin Exp Metastasis. 2006, 23: 301-13. 10.1007/s10585-006-9040-z.CrossRefPubMed
30.
go back to reference Habets GG, Scholtes EH, Zuydgeest D, et al: Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell. 1994, 77: 537-49. 10.1016/0092-8674(94)90216-X.CrossRefPubMed Habets GG, Scholtes EH, Zuydgeest D, et al: Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell. 1994, 77: 537-49. 10.1016/0092-8674(94)90216-X.CrossRefPubMed
31.
go back to reference Gardell SE, Dubin AE, Chun J: Emerging medicinal roles for lysophospholipid signaling. Trends Mol Med. 2006, 12: 65-75. 10.1016/j.molmed.2005.12.001.CrossRefPubMed Gardell SE, Dubin AE, Chun J: Emerging medicinal roles for lysophospholipid signaling. Trends Mol Med. 2006, 12: 65-75. 10.1016/j.molmed.2005.12.001.CrossRefPubMed
32.
go back to reference Murph M, Tanaka T, Liu S, et al: Of spiders and crabs: the emergence of lysophospholipids and their metabolic pathways as targets for therapy in cancer. Clin Cancer Res. 2006, 12: 6598-602. 10.1158/1078-0432.CCR-06-1721.CrossRefPubMed Murph M, Tanaka T, Liu S, et al: Of spiders and crabs: the emergence of lysophospholipids and their metabolic pathways as targets for therapy in cancer. Clin Cancer Res. 2006, 12: 6598-602. 10.1158/1078-0432.CCR-06-1721.CrossRefPubMed
33.
go back to reference Ernst M, Najdovska M, Grail D, et al: STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest. 2008, 118: 1727-38.PubMedPubMedCentral Ernst M, Najdovska M, Grail D, et al: STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest. 2008, 118: 1727-38.PubMedPubMedCentral
34.
go back to reference Regis G, Pensa S, Boselli D, et al: Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling. Semin Cell Dev Biol. 2008, 19: 351-9. 10.1016/j.semcdb.2008.06.004.CrossRefPubMed Regis G, Pensa S, Boselli D, et al: Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling. Semin Cell Dev Biol. 2008, 19: 351-9. 10.1016/j.semcdb.2008.06.004.CrossRefPubMed
35.
go back to reference Uyttenhove C, Pilotte L, Theate I, et al: Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med. 2003, 9: 1269-74. 10.1038/nm934.CrossRefPubMed Uyttenhove C, Pilotte L, Theate I, et al: Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med. 2003, 9: 1269-74. 10.1038/nm934.CrossRefPubMed
36.
go back to reference Torrero MN, Xia X, Henk W, et al: Stat1 deficiency in the host enhances interleukin-12-mediated tumor regression. Cancer Res. 2006, 66: 4461-7. 10.1158/0008-5472.CAN-05-3554.CrossRefPubMed Torrero MN, Xia X, Henk W, et al: Stat1 deficiency in the host enhances interleukin-12-mediated tumor regression. Cancer Res. 2006, 66: 4461-7. 10.1158/0008-5472.CAN-05-3554.CrossRefPubMed
37.
go back to reference Mitas M, Almeida JS, Mikhitarian K, et al: Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCR. Clin Cancer Res. 2005, 11: 2205-14. 10.1158/1078-0432.CCR-04-1091.CrossRefPubMed Mitas M, Almeida JS, Mikhitarian K, et al: Accurate discrimination of Barrett's esophagus and esophageal adenocarcinoma using a quantitative three-tiered algorithm and multimarker real-time reverse transcription-PCR. Clin Cancer Res. 2005, 11: 2205-14. 10.1158/1078-0432.CCR-04-1091.CrossRefPubMed
38.
go back to reference Brabender J, Marjoram P, Salonga D, et al: A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus. Oncogene. 2004, 23: 4780-8. 10.1038/sj.onc.1207663.CrossRefPubMed Brabender J, Marjoram P, Salonga D, et al: A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus. Oncogene. 2004, 23: 4780-8. 10.1038/sj.onc.1207663.CrossRefPubMed
39.
go back to reference Scholz CJ, Kurzeder C, Koretz K, et al: Tspan-1 is a tetraspanin preferentially expressed by mucinous and endometrioid subtypes of human ovarian carcinomas. Cancer Lett. 2009, 275: 198-203. 10.1016/j.canlet.2008.10.014.CrossRefPubMed Scholz CJ, Kurzeder C, Koretz K, et al: Tspan-1 is a tetraspanin preferentially expressed by mucinous and endometrioid subtypes of human ovarian carcinomas. Cancer Lett. 2009, 275: 198-203. 10.1016/j.canlet.2008.10.014.CrossRefPubMed
40.
go back to reference Chen L, Li X, Wang GL, et al: Clinicopathological significance of overexpression of TSPAN1, Ki67 and CD34 in gastric carcinoma. Tumori. 2008, 94: 531-8.PubMed Chen L, Li X, Wang GL, et al: Clinicopathological significance of overexpression of TSPAN1, Ki67 and CD34 in gastric carcinoma. Tumori. 2008, 94: 531-8.PubMed
41.
go back to reference Ma C, Rong Y, Radiloff DR, et al: Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev. 2008, 22: 308-21. 10.1101/gad.1632008.CrossRefPubMedPubMedCentral Ma C, Rong Y, Radiloff DR, et al: Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev. 2008, 22: 308-21. 10.1101/gad.1632008.CrossRefPubMedPubMedCentral
42.
go back to reference Sugasawa H, Ichikura T, Kinoshita M, et al: gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination. Int J Cancer. 2008, 122: 2535-41. 10.1002/ijc.23401.CrossRefPubMed Sugasawa H, Ichikura T, Kinoshita M, et al: gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination. Int J Cancer. 2008, 122: 2535-41. 10.1002/ijc.23401.CrossRefPubMed
43.
go back to reference Citri A, Yarden Y: EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol. 2006, 7: 505-16. 10.1038/nrm1962.CrossRefPubMed Citri A, Yarden Y: EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol. 2006, 7: 505-16. 10.1038/nrm1962.CrossRefPubMed
44.
go back to reference O'Dwyer PJ, Benson AB: Epidermal growth factor receptor-targeted therapy in colorectal cancer. Semin Oncol. 2002, 29: 10-7.CrossRefPubMed O'Dwyer PJ, Benson AB: Epidermal growth factor receptor-targeted therapy in colorectal cancer. Semin Oncol. 2002, 29: 10-7.CrossRefPubMed
45.
go back to reference Mendelsohn J, Baselga J: Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol. 2003, 21: 2787-99. 10.1200/JCO.2003.01.504.CrossRefPubMed Mendelsohn J, Baselga J: Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol. 2003, 21: 2787-99. 10.1200/JCO.2003.01.504.CrossRefPubMed
46.
go back to reference Shida D, Fang X, Kordula T, et al: Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion. Cancer Res. 2008, 68: 6569-77. 10.1158/0008-5472.CAN-08-0411.CrossRefPubMedPubMedCentral Shida D, Fang X, Kordula T, et al: Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion. Cancer Res. 2008, 68: 6569-77. 10.1158/0008-5472.CAN-08-0411.CrossRefPubMedPubMedCentral
47.
go back to reference Park BH, Vogelstein B, Kinzler KW: Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells. Proc Natl Acad Sci USA. 2001, 98: 2598-603. 10.1073/pnas.051630998.CrossRefPubMedPubMedCentral Park BH, Vogelstein B, Kinzler KW: Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells. Proc Natl Acad Sci USA. 2001, 98: 2598-603. 10.1073/pnas.051630998.CrossRefPubMedPubMedCentral
48.
go back to reference Jaeckel EC, Raja S, Tan J, et al: Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor delta with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2001, 127: 1253-9.CrossRefPubMed Jaeckel EC, Raja S, Tan J, et al: Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor delta with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2001, 127: 1253-9.CrossRefPubMed
49.
go back to reference Tong BJ, Tan J, Tajeda L, et al: Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma. Neoplasia. 2000, 2: 483-90. 10.1038/sj.neo.7900119.CrossRefPubMedPubMedCentral Tong BJ, Tan J, Tajeda L, et al: Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma. Neoplasia. 2000, 2: 483-90. 10.1038/sj.neo.7900119.CrossRefPubMedPubMedCentral
50.
go back to reference Yakar S, Leroith D, Brodt P: The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models. Cytokine Growth Factor Rev. 2005, 16: 407-20. 10.1016/j.cytogfr.2005.01.010.CrossRefPubMed Yakar S, Leroith D, Brodt P: The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models. Cytokine Growth Factor Rev. 2005, 16: 407-20. 10.1016/j.cytogfr.2005.01.010.CrossRefPubMed
51.
go back to reference Durai R, Yang W, Gupta S, et al: The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge. Int J Colorectal Dis. 2005, 20: 203-20. 10.1007/s00384-004-0675-4.CrossRefPubMed Durai R, Yang W, Gupta S, et al: The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge. Int J Colorectal Dis. 2005, 20: 203-20. 10.1007/s00384-004-0675-4.CrossRefPubMed
52.
go back to reference Matsubara J, Yamada Y, Nakajima TE, et al: Clinical significance of insulin-like growth factor type 1 receptor and epidermal growth factor receptor in patients with advanced gastric cancer. Oncology. 2008, 74: 76-83. 10.1159/000139127.CrossRefPubMed Matsubara J, Yamada Y, Nakajima TE, et al: Clinical significance of insulin-like growth factor type 1 receptor and epidermal growth factor receptor in patients with advanced gastric cancer. Oncology. 2008, 74: 76-83. 10.1159/000139127.CrossRefPubMed
53.
go back to reference Coronas S, Lagarrigue F, Ramel D, et al: Elevated levels of PtdIns5P in NPM-ALK transformed cells: implication of PIKfyve. Biochem Biophys Res Commun. 2008, 372: 351-5. 10.1016/j.bbrc.2008.05.062.CrossRefPubMed Coronas S, Lagarrigue F, Ramel D, et al: Elevated levels of PtdIns5P in NPM-ALK transformed cells: implication of PIKfyve. Biochem Biophys Res Commun. 2008, 372: 351-5. 10.1016/j.bbrc.2008.05.062.CrossRefPubMed
54.
go back to reference Kim J, Jahng WJ, Di Vizio D, et al: The phosphoinositide kinase PIKfyve mediates epidermal growth factor receptor trafficking to the nucleus. Cancer Res. 2007, 67: 9229-37. 10.1158/0008-5472.CAN-07-1333.CrossRefPubMedPubMedCentral Kim J, Jahng WJ, Di Vizio D, et al: The phosphoinositide kinase PIKfyve mediates epidermal growth factor receptor trafficking to the nucleus. Cancer Res. 2007, 67: 9229-37. 10.1158/0008-5472.CAN-07-1333.CrossRefPubMedPubMedCentral
Metadata
Title
A functional and transcriptomic analysis of NET1 bioactivity in gastric cancer
Authors
Gayle Bennett
Denise Sadlier
Peter P Doran
Padraic MacMathuna
David W Murray
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2011
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-11-50

Other articles of this Issue 1/2011

BMC Cancer 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine